ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer

Wu, Han; Zhao, Xibo; Wang, Jing; Jiang, Xinyan; Cheng, Yan; He, Yanan; Sun, Liyuan; Zhang, Guangmei*哈尔滨医科大学; 1
Frontiers in Genetics2022-1-26DOI: 10.3389/fgene.2021.815448
6被引6阅读
引用收藏
分享

摘要

Cisplatin (CDDP) chemoresistance seriously affects the prognosis and survival of patients with ovarian cancer (OC). Previous research has shown that circular RNA CDR1as is biologically associated with a large number of cancers. However, the molecular mechanism underlying the role of CDR1as in CDDP chemoresistance in OC remains unclear. Here, we investigated the mechanism of CDR1as in CDDP-resistant OC. First, we employed bioinformatics analysis and quantitative real-time PCR (qRT-PCR) to determine the expression of CDR1as and related RNAs in CDDP-sensitive and -resistant OC tissues and cells. Then, functional experiments were used to determine cell proliferation, invasion, migration, and apoptosis in CDDP chemoresistance and parent OC cells in vitro. The effect of CDR1as in CDDP chemoresistance OC progression was tested in nude mice in vivo. Moreover, dual-luciferase assays and RNA immunoprecipitation (RIP) were performed to confirm the interactions of CDR1as and related RNAs. Finally, we used Western blotting to determine protein expression levels. Our findings interpret the underlying mechanisms of the CDR1as/miR-1299/PPP1R12B axis and shed light on the clinical applications for CDDP-chemoresistant OC.

学科与关键词

关键词
ovarian cancercisplatin chemoresistanceCDR1asmiR-1299
相关
加载中…
  • CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression
    Huang, Chunyan; Qin, Li; Chen, Sailan; Huang, Qin*Anti-Cancer Drugs, 2023, 34(3): 395-404.被引 2
  • Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
    Li, Weijia; Zhao, Xibo; Zhang, Rujian; Xie, Jiabin; Zhang, Guangmei*Mediators of Inflammation, 2023, 2023: 7700673.
  • Silencing circular RNA-friend leukemia virus integration 1 restrained malignancy of CC cells and oxaliplatin resistance by disturbing dyskeratosis congenita 1
    Liu, Weipeng*; Jiang, Hong; Li, YuanqiangOpen Life Sciences, 2022, 17(1): 563-576.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-01-26
卷期
第 12 卷
页码
815448
DOI
10.3389/fgene.2021.815448
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81772780]

作者

  • W

    Wu, Han (第一作者)

    1 · harbin med univ

  • Z

    Zhao, Xibo

    1 · harbin med univ

查看全部 8 位作者收起作者
  • W

    Wang, Jing

    1 · harbin med univ

  • J

    Jiang, Xinyan

    1 · harbin med univ

  • C

    Cheng, Yan

    1 · harbin med univ

  • H

    He, Yanan

    1 · harbin med univ

  • S

    Sun, Liyuan

    1 · harbin med univ

  • Z

    Zhang, Guangmei (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417